One of the key mechanisms observed in the tissues impacted by type 2 diabetes is that PI3K/Akt-mediated NF-κB signaling might be a mechanism for the treatment of DN [16]. The gene discussed is NFKB1; the disease is type 2 diabetes mellitus.